Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04779049Aexternal-prioritypatent/EP1682553B1/en
Application filed by Aventis Pharmaceuticals Inc.filedCriticalAventis Pharmaceuticals Inc.
Publication of CY1110743T1publicationCriticalpatent/CY1110743T1/en
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur
(AREA)
Abstract
Θειενοπυραζόλια, η παρασκευή τους, φαρμακευτικές συνθέσεις που περιέχουν τις εν λόγω ενώσεις και οι φαρμακευτικές τους χρήσεις στη θεραπευτική αντιμετώπιση παθήσεων που είναι σε θέση να ρυθμιστούν δια της αναστολής πρωτεϊνικών κινασών, ιδίως της επαγώγιμης δια ιντελευκίνης-2 τυροσινικής κινάσης (ΙΤΚ).Thienopyrazoles, their preparation, pharmaceutical compositions containing said compounds, and their pharmaceutical uses in the treatment of diseases capable of being regulated by inhibition of protein kinases, in particular inducible tyrosine kinase-2 (tyrosine kinase) -induced.